Beijing Beilu Pharmaceutical Co., Ltd.

Beijing Beilu Pharmaceutical Co., Ltd. saw a notable decline in its stock price today, contrasting with the broader market's performance. Despite recent downturns, the company has shown resilience over the past year, achieving significant stock value growth. Financial metrics indicate steady net sales growth, though long-term outlooks raise concerns.

Beijing Beilu Pharmaceutical Co., Ltd. has seen notable stock performance, with a significant increase on March 6, 2026. The company reported strong financial growth, including a 21.13% rise in net sales and a net profit of CNY 25.38 million for the half-year, reflecting its resilience in the pharmaceuticals sector.

Beijing Beilu Pharmaceutical Co., Ltd. has shown notable stock performance, gaining 6.31% on March 5, 2026, and achieving an intraday high of CNY 10.20. Over the past year, the company has delivered a 51.12% return, with strong net sales and operating cash flow, reflecting solid financial health.